Join us on an amazing journey towards next‐generation treatments for CNS disorders: Launch of Neuroprotection, a new high‐quality journal in translational neuroscience
Year: 2022
Type: article
Abstract: Translational medicine in neurodegenerative and neurovascular diseases is approaching a breakthrough point.Recent years have led to dramatic progress in both experimental and clinical research.Based on a much better and continuously increasing understanding of disease mechanisms, progression and pathophysiology, new therapies with an improved translational potential to protect tissue either against acute or chronic degeneration and even approaches potentially capable of repairing damaged brain tissue are emerging.
DOI: 10.1002/nep3.8
Institutions: Capital Medical University, Beijing Institute for Brain Disorders, University of Maryland, Baltimore, Erasmus MC, Essen University Hospital, Stiftung Universitätsmedizin Essen, Brain Research New Zealand, University of Nottingham, Queen's Medical Centre, University of Eastern Finland, University of Pittsburgh, McGowan Institute for Regenerative Medicine, Universidade Federal do Rio de Janeiro, Lund University, Daping Hospital, Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences, University of Vienna, Beijing Shijitan Hospital, University of Warwick
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
Awards: In Vivo Fluorescence and Bioluminescence Imager with CT, Mesoscopic Diffusion-based MRI Histology of Epileptic Human Hippocampi, G3418612396, Shedding light on functional heterogeneity of dementia-related alpha-synuclein strains, G4204068617, G4787400991, Intravital 2-photon microscopy enabling 6D single cell RNA seq in immunocompetent glioblastoma xenografts, Enhancing Neurogenesis for Brain Tissue Regeneration
OpenAlex ID: W4294409072